home / stock / cvac / cvac news


CVAC News and Press, CureVac N.V. From 04/04/24

Stock Information

Company Name: CureVac N.V.
Stock Symbol: CVAC
Market: NASDAQ

Menu

CVAC CVAC Quote CVAC Short CVAC News CVAC Articles CVAC Message Board
Get CVAC Alerts

News, Short Squeeze, Breakout and More Instantly...

CVAC - CureVac posts early efficacy results for GSK-partnered flu shot

2024-04-04 08:20:35 ET More on CureVac BV CureVac: No Momentum In Sight Seeking Alpha’s Quant Rating on CureVac BV Historical earnings data for CureVac BV Financial information for CureVac BV Read the full article on Seeking Alpha For f...

CVAC - CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK

Seasonal flu vaccine candidate boosted antibody titers at all dose levels and for all encoded seasonal influenza strains across younger and older adults Potentially differentiated, multivalent candidate encodes antigens matched to all four WHO-recommended flu strains For influenza A s...

CVAC - CureVac: No Momentum In Sight

2024-03-08 10:11:10 ET Summary CureVac faces challenges as a German court invalidates one of their key mRNA technology patents, raising concerns about their ability to compete in the mRNA space. The invalidated patent relates to an invention that many argue was not a genuine "inve...

CVAC - CureVac, Grifols among healthcare movers

2024-01-12 10:00:21 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Health stocks to watch this earnings season as sector poised for resurgence Seeking Al...

CVAC - CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform

Head-to-head comparison with licensed bivalent mRNA-based comparator vaccine confirms competitive immune responses at lower doses and favorable tolerability profile Monovalent mRNA vaccine candidate, CV0601, encoding Omicron BA.4-5 variant and bivalent candidate, CV0701, encoding Omicron BA....

CVAC - GPRO, WPRT and GH are among after hour movers

2023-12-19 16:50:11 ET Gainers: Shimmick Corporation ( SHIM ) +11% . Westport Fuel Systems  ( WPRT ) +5% . Telos Corporation ( TLS ) +2% . NN ( NNBR ) +2% . CureVac  ( CVAC ) +2% . Losers: Guardant Health ( GH...

CVAC - CureVac plunges after German court rules against it in BionTech patent challenge

2023-12-19 14:00:10 ET More on CureVac BV CureVac: Failing To Live Up To Its Initial Hype CureVac N.V. (CVAC) Q3 2023 Earnings Call Transcript CureVac N.V. 2023 Q3 - Results - Earnings Call Presentation CureVac slips as court pauses mRNA patent trial against ...

CVAC - CVAC, REE and NEON among mid-day movers

2023-12-19 12:49:04 ET Gainers: Panbela Therapeutics ( PBLA ) +54% . Singlepoint ( SING ) +41% . MedAvail Holdings ( MDVL ) +32% . REE Automotive Ltd ( REE ) +29% . Pulse Biosciences ( PLSE ) +28% . Neonode ( NEON ) +25...

CVAC - CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE

Validity of CureVac patent EP 1 857 122 B1 denied by German Federal Patent Court after nullity action filed by BioNTech SE Decision does not affect ongoing litigation in Germany regarding seven other intellectual property rights, covering strong foundational as well as COVID-19-specific mRNA...

CVAC - Pfizer hits 52-week low, drags COVID vaccine peers on weak guidance

2023-12-13 11:18:26 ET More on Pfizer Johnson & Johnson Vs. Pfizer: Better Pharma Stock? Pfizer: This Year's Disaster Should Set The Stage For A Strong 2024 Pfizer: Slimming Down After COVID Franchise And Obesity Pipeline Setbacks Biggest stock movers tod...

Previous 10 Next 10